ROGER WILLIAMS MEDICAL CENTER
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1878-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.rwmc.org
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT00664196
- Locations
- ๐บ๐ธ
Roger Williams Medical Center, Providence, Rhode Island, United States
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT00569296
- Locations
- ๐บ๐ธ
Roger Williams Medical Center, Providence, Rhode Island, United States
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2007-01-31
- Last Posted Date
- 2012-03-02
- Lead Sponsor
- Roger Williams Medical Center
- Registration Number
- NCT00429078
Gene Therapy in Treating Patients With Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2004-04-19
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Roger Williams Medical Center
- Registration Number
- NCT00004178
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00002681
- Locations
- ๐บ๐ธ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Roger Williams Medical Center
- Registration Number
- NCT00022230
- Locations
- ๐บ๐ธ
Roger Williams Medical Center, Providence, Rhode Island, United States
Bioengineered Skin and Wound Healing
Phase 1
Completed
- Conditions
- First Posted Date
- 2000-12-18
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Roger Williams Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00007280
- Locations
- ๐บ๐ธ
Roger Williams Medical Center Dept. of Dermatology & Skin Surgery, Providence, Rhode Island, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath